CCCS Holds Public Consultation on Proposed TalkMed Acquisition
CCCS Holds Public Consultation on Proposed TalkMed Acquisition
THL is active in medical oncology in Singapore. Outside of Singapore, THL's activities include post-cancer, advisory and consultation services in Malaysia; medical and radiation oncology services in the Philippines, and oncology services in Hong Kong.The consultation will determine whether the acquisition by Tamarind Health would be anti-competitive.
磋商將確定羅望子健康的收購是否會反競爭。
The Competition and Consumer Commission of Singapore (CCCS) is inviting public feedback on the proposed acquisition of TalkMed Group by Tamarind Health Limited (THL).
新加坡競爭與消費者委員會（CCCS）正在就塔瑪琳德健康有限公司（THL）收購TALKMED集團的提議徵求公衆反饋意見。
Last 13 January, CCCS accepted a joint application from both companies for a decision on whether the transaction would be anti-competitive.
去年1月13日，CCCS接受了兩家公司的聯合申請，要求就該交易是否反競爭做出決定。
THL is active in medical oncology in Singapore. Outside of Singapore, THL's activities include post-cancer, advisory and consultation services in Malaysia; medical and radiation oncology services in the Philippines, and oncology services in Hong Kong.
THL 活躍於新加坡的腫瘤內科。在新加坡以外，THL的活動包括馬來西亞的癌後服務、諮詢和諮詢服務；菲律賓的醫學和放射腫瘤學服務，以及香港的腫瘤學服務。
Meanwhile, TalkMed provides medical oncology services, adult and paediatric blood disorders treatment, haematologic malignancies and palliative healthcare services. The group also provides cellular and gene therapy-related products and services.
同時，TalkMed提供腫瘤內科服務、成人和兒童血液疾病治療、血液系統惡性腫瘤和姑息醫療保健服務。該集團還提供與細胞和基因療法相關的產品和服務。
TW Troy Limited, an indirectly wholly-owned subsidiary of THL, will acquire all the issued and paid shares in TalkMed.
THL的間接全資子公司TW Troy Limited將收購TalkMed的所有已發行和已付股份。
Public feedback can be submitted starting 21 January to 5:00 pm on 31 January.
公衆反饋可以從1月21日起至1月31日下午5點提交。
熱門市場機會
熱門討論
熱門討論
